News

WHO’s new priority list of antibiotic-resistant bacteria looks beyond the scourge of tuberculosis. By Marie-Paule Kieny March 13, 2017. Reprints. A doctor examines the X-rays of a tuberculosis ...
Today, WHO released its first-ever list of antibiotic-resistant “priority pathogens” that pose the greatest threat to human health. The list is intended to promote research and development of ...
For decades, antibiotics have been used successfully to fight a wide range of bacterial infections. However, overuse of these medicines has led to the development of antibiotic-resistant bacteria ...
The list, which was released Monday, enumerates 12 bacterial threats, grouping them into three categories: ... “Antibiotic resistance is growing and we are running out of treatment options.
The list, which was compiled by researchers at the University of Tübingen in Germany, shares similarities with a document published by the CDC back in 2013, which zeroed in on 18 antibiotic ...
Each year, superbugs -- viral bacterial infections resistant to common antibiotics -- infect more than two million Americans, killing at least 38,000. As the list of antibiotic-resistant bacteria ...
The World Health Organization on Feb. 27 published its first-ever list of antibiotic-resistant "priority pathogens," as the UN agency termed them – 12 families of bacteria that pose the greatest ...
While releasing the list to spur R&D, the WHO emphasizes that more is needed to fight antibiotic resistance—specifically, improved prevention control and appropriate use of antibiotics.
People often come into the emergency department with a long list of antibiotics they say they’re allergic to. The problem with this is there may not be many options left for the doctor to ...
The 2024 Bacterial Priority Pathogens List (BPPL) includes 15 families of antibiotic-resistant bacteria categorized as critical, high, and medium for prioritization.
For the first time ever, the World Health Organization has drawn up a list of the highest priority needs for new antibiotics — marching orders, it hopes, for the pharmaceutical industry.